Your browser doesn't support javascript.
loading
Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer.
de Heer, E C; Hulshoff, J B; Klerk, D; Burgerhof, J G M; de Groot, D J A; Plukker, J Th M; Hospers, G A P.
Afiliação
  • de Heer EC; Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Hulshoff JB; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • Klerk D; Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Burgerhof JGM; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • de Groot DJA; Department of Epidemiology, University of Groningen, Groningen, The Netherlands.
  • Plukker JTM; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • Hospers GAP; Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Ann Surg Oncol ; 24(7): 1811-1820, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28188501
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Adenocarcinoma / Esofagectomia / Terapia Neoadjuvante / Quimiorradioterapia Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Adenocarcinoma / Esofagectomia / Terapia Neoadjuvante / Quimiorradioterapia Idioma: En Ano de publicação: 2017 Tipo de documento: Article